Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in Cholangiocarcinoma
Molecular & Cellular Proteomics · 2025-11 · 24 (11) · 101084
DOI: 10.1016/j.mcpro.2025.101084 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Molecular & Cellular Proteomics, 2025-11. Verfasst von Zhili Xia und 18 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Proteomics, Glycoproteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) comprises intrahepatic (iCCA) and extrahepatic (eCCA) subtypes, each exhibiting distinct molecular characteristics. Understanding these differences is critical for identifying subtype-specific therapeutic targets and advancing precision medicine. Protein glycosylation, a key post-translational modification, regulates immune evasion and metastasis, yet the glycoproteomic difference between iCCA and eCCA remains unexplored. Here we presented the first comprehensive N-glycoproteomic profile of eCCA and compared it with iCCA using a publicly available dataset. Our N-glycoproteomic analysis of paired eCCA tumors and normal adjacent tissues (NATs) identified 8372 N-glycopeptides, 3467 N-glycosites, and 2627 N-glycoproteins. Comparative analysis revealed distinct N-glycosylation signature, with eCCA exhibiting higher fucosylated glycans and iCCA showing increased sialylation. Pathway enrichment analysis of N-glycoproteins revealed a more prominent lysosome-related enrichment in eCCA, whereas pathways related to immune modulation, cytoskeletal components, and the extracellular matrix were significantly enriched in both subtypes. Immune profiling revealed an immunosuppressive microenvironment in both eCCA and iCCA, characterized by reduced natural killer cell infiltration and subtype-specific fibroblast and endothelial cell remodeling. DPM1, a glycosylation enzyme highly expressed in eCCA, was associated with tumor-specific N-glycopeptides and reduced immune cell infiltration. Its knockdown impaired cell migration, and glycoproteomic analysis implicated DPM1 in regulating adhesion, proteostasis, and immune pathways, highlighting its potential as a therapeutic target in eCCA. Our findings provide insights into N-glycosylation alterations in CCA subtypes, underscoring N-glycosylation-related mechanisms as potential biomarkers and therapeutic targets, particularly in eCCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
- National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China; Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou, China.
- Gansu Province Key Laboratory of Biological Therapy and Regenerative Medicine Transformation, Lanzhou, China.
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China; Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Key Laboratory of Biological Therapy and…
- National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Electronic address: niqiu.er@163.com.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Xia, Z., Gao, L., Hu, M., Li, Y., Yu, K., Jiang, N., Gao, L., Liu, Y., Lu, Y., Ren, Y., Tian, C., Lu, Y., Zhang, J., Yu, H., Yue, P., Lin, Y., Zhang, R., Gong, Y., & Meng, W. (2025). Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in Cholangiocarcinoma. Molecular & Cellular Proteomics, 24(11), 101084. https://doi.org/10.1016/j.mcpro.2025.101084
Vancouver
Xia Z, Gao L, Hu M, Li Y, Yu K, Jiang N, et al. Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in Cholangiocarcinoma. Molecular & Cellular Proteomics. 2025;24(11):101084. doi:10.1016/j.mcpro.2025.101084
BibTeX
@article{Xia2025,
author = {Xia, Zhili and Gao, Li and Hu, Meng and Li, Yingjie and Yu, Kexin and Jiang, Ningzu and Gao, Long and Liu, Yu and Lu, Ying and Ren, Yanxian and Tian, Chenjun and Lu, Yawen and Zhang, Jindu and Yu, Haiying and Yue, Ping and Lin, Yanyan and Zhang, Rou and Gong, Yanqiu and Meng, Wenbo},
title = {Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in Cholangiocarcinoma},
journal = {Molecular & Cellular Proteomics},
year = {2025},
volume = {24},
number = {11},
pages = {101084},
doi = {10.1016/j.mcpro.2025.101084}
}
EUVIMED